SEC Tracker
Get the app

Maze Therapeutics MAZE

Maze Therapeutics exchanges stock for warrants

Form
8-K
Filed
Importance
Routine
  1. Exchanged 2,776,007 shares for warrants
  2. Warrants allow purchase of 2,776,007 shares
  3. Outstanding shares now 53,931,889
  4. Warrants issued without registration

Written from the 8-K on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Maze Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2836 and related industry codes: the same peer list as the financial tables.

  1. Theravance Biopharma TBPH public float $449M, Jun 30, 2025
  2. Zevra Therapeutics ZVRA public float $455M, Jun 30, 2025
  3. aTYR PHARMA ATYR public float $464M, Jun 30, 2025
  4. Arvinas ARVN public float $469M, Jun 30, 2025
  5. CytoDyn CYDY public float $418M, Nov 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.